Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (371-380 of 600) with videos related to

Pageof 60
Sort By:
The Journal of Rheumatology|September 1, 2004
Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distanceLiesbeth Heuft-Dorenbosch, Debby Vosse, Robert Landewé, et al.
Arthritis Research & Therapy|February 14, 2019
Deregulation of microRNA expression in monocytes and CD4<sup>+</sup> T lymphocytes from patients with axial spondyloarthritisOlivier Fogel, Andreas Bugge Tinggaard, Maud Fagny, et al.
Annals of the Rheumatic Diseases|September 28, 2014
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendationsDésirée van der Heijde, Daniel Aletaha, Loreto Carmona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Rate and Predisposing Factors for Sacroiliac Joint Radiographic Progression After a Two-Year Follow-up Period in Recent-Onset SpondyloarthritisMaxime Dougados, Christophe Demattei, Rosaline van den Berg, et al.
The Journal of Rheumatology|October 3, 2012
Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX studyEdward C Keystone, Stanley B Cohen, Paul Emery, et al.
Annals of the Rheumatic Diseases|November 30, 2017
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre studyAnna Moltó, Adrien Etcheto, Laure Gossec, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Joint Bone Spine|January 1, 2024
Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception CohortMaxime Dougados, Chris Serrand, Sandrine Alonso, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
Arthritis Care & Research|October 25, 2018
Spinal Radiographic Progression in Early Axial Spondyloarthritis: Five-Year Results From the DESIR CohortSofia Ramiro, Désirée van der Heijde, Alexandre Sepriano, et al.
Pageof 60

Showing results (371-380 of 600) with videos related to

Sort By:
Pageof 60
The Journal of Rheumatology|September 1, 2004
Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distanceLiesbeth Heuft-Dorenbosch, Debby Vosse, Robert Landewé, et al.
Arthritis Research & Therapy|February 14, 2019
Deregulation of microRNA expression in monocytes and CD4<sup>+</sup> T lymphocytes from patients with axial spondyloarthritisOlivier Fogel, Andreas Bugge Tinggaard, Maud Fagny, et al.
Annals of the Rheumatic Diseases|September 28, 2014
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendationsDésirée van der Heijde, Daniel Aletaha, Loreto Carmona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Rate and Predisposing Factors for Sacroiliac Joint Radiographic Progression After a Two-Year Follow-up Period in Recent-Onset SpondyloarthritisMaxime Dougados, Christophe Demattei, Rosaline van den Berg, et al.
The Journal of Rheumatology|October 3, 2012
Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX studyEdward C Keystone, Stanley B Cohen, Paul Emery, et al.
Annals of the Rheumatic Diseases|November 30, 2017
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre studyAnna Moltó, Adrien Etcheto, Laure Gossec, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Joint Bone Spine|January 1, 2024
Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception CohortMaxime Dougados, Chris Serrand, Sandrine Alonso, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
Arthritis Care & Research|October 25, 2018
Spinal Radiographic Progression in Early Axial Spondyloarthritis: Five-Year Results From the DESIR CohortSofia Ramiro, Désirée van der Heijde, Alexandre Sepriano, et al.
Pageof 60